Varro Bio Featured in St. Louis Magazine

Recall how long it took, in the depths of the COVID-19 pandemic, to screen yourself with the gold-standard method, the PCR test: You’d swab your nostrils, hand the swab to the person at the pharmacy or clinic, then wait while they sent it off to a lab for processing. Yes, the result was highly reliable, but it took days.  

The St. Louis biotech startup Varro Life Sciences has developed a biosensor that’s of comparable sensitivity but takes only 60 seconds to deliver results. And it can detect more than just the next coronavirus: The company estimates that within a few weeks of the emergence of any airborne virus, bacterium, or fungal pathogen—say, the latest flu or strep—the company will be able to make a biosensor that can recognize it. 

To continue reading on the publication’s website, click here.